Metraipolis › archive › dc_cc995c10e372

Managing fatigue with methylphenidate and physical activity during cancer immunotherapy treatment — Europe PMC PMID:41423710

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41423710
DOI
10.1017/s1478951525101375
License (as archived)
solo-consultazione
Archived
2026-11-07T11:42:51.994Z
SHA-256 of the archived text
dd5983b58bfada0b234b063615a630b7868d64350af136c095aebf0babcefdbc
Stable URL of this page
https://metraipolis.com/documento/dc_cc995c10e372

How to cite

Managing fatigue with methylphenidate and physical activity during cancer immunotherapy treatment — Europe PMC PMID:41423710 — Europe PMC (en), https://europepmc.org/article/MED/41423710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc995c10e372 (Metraipolis archive dc_cc995c10e372, sha256 dd5983b58bfada0b234b063615a630b7868d64350af136c095aebf0babcefdbc)
BibTeX
@misc{dccc995c10e372,
  title = {Managing fatigue with methylphenidate and physical activity during cancer immunotherapy treatment — Europe PMC PMID:41423710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41423710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc995c10e372; sha256 dd5983b58bfada0b234b063615a630b7868d64350af136c095aebf0babcefdbc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41423710. Agents can read the archived copy with the MCP tool read_document.